Can-Fite raises $4 million through warrant exercise agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/20/2026

1. BRZE
2. SPY
3. META
4. ZION
5. RAPP
6. AMZN
7. MMM
8. NFLX
9. IBM
10. IRON

Go back to Can-Fite raises $4 million through warrant exercise agreement

Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds

March 4, 2026 10:25 AM EST

RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (Can-Fite or the Company), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the... More